170707-46-7

Basic information

• Product Name: C₂₈H₂₁N₃O₂
• Synonyms: C₂₈H₂₁N₃O₂
• CAS NO: 170707-46-7
• Molecular Weight: 431.494
• Mol File: 170707-46-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: C₂₈H₂₁N₃O₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₈H₂₁N₃O₂(170707-46-7)
• EPA Substance Registry System: C₂₈H₂₁N₃O₂(170707-46-7)

Safety Data

• Hazardous Substances Data: 170707-46-7(Hazardous Substances Data)

Upstream product

• 40899-99-8 2,2'-biindole 
• 170707-44-5 3-Diazo-1-(4-methoxy-benzyl)-pyrrolidine-2,4-dione 
• 703405-37-2 C₂₈H₂₁N₃O₃ 
• 171824-52-5 2-Methyl-4,7-bis-(2-nitro-phenyl)-isoindole-1,3-dione 
• 137592-49-5 N₆-methylarcyriaflavin A 
• 115684-58-7 6,7,12,13-tetrahydro-5,7-dioxo-5H-indolo<2,3-a>furo<3,4-c>carbazole 
• 23308-83-0 (2-nitrobenzyl)triphenylphosphonium bromide 
• 87259-89-0 (E,E)-1,4-bis(2-nitrophenyl)buta-1,3-diene 
• 1466-88-2 2-nitrocinnamic aldehyde 
• 195708-86-2 4-Hydroxy-1-(4-methoxy-benzyl)-2-oxo-2,5-dihydro-1H-pyrrole-3-carboxylic acid ethyl ester 
• 60857-16-1 N-(4-methoxybenzyl)glycine ethyl ester 
• 171824-53-6 C₂₈H₁₉N₃O₃ 

Downstream Products

• 97161-97-2 (+/-)-K252a 

Relevant articles and documents

N,N-BRIDGED, NITROGEN-SUBSTITUTED CARBACYCLIC INDOLOCARBAZOLES AS PROTEIN KINASE INHIBITORS

The present invention relates to novel protein kinase inhibitors with advantageous pharmaceutical properties, methods for their preparation, intermediates thereof and pharmaceutical compositions comprising the same, reagents containing the same, and methods of using the same as therapeutics, particularly in CNS diseases.

The Total Synthesis of (+/-)K252a

The total synthesis of (+/-)K252a (1) has been achieved following a convergent approach in which an acid-catalyzed bis-glycosidation reaction serves as a key step.